These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 20830766

  • 1. Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol.
    Albert M, Kiefer MV, Sun W, Haller D, Fraker DL, Tuite CM, Stavropoulos SW, Mondschein JI, Soulen MC.
    Cancer; 2011 Jan 15; 117(2):343-52. PubMed ID: 20830766
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, Crippin JS.
    J Vasc Interv Radiol; 2005 Dec 15; 16(12):1661-6. PubMed ID: 16371533
    [Abstract] [Full Text] [Related]

  • 4. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
    Leichman CG, Jacobson JR, Modiano M, Daniels JR, Zalupski MM, Doroshow JH, Fletcher WS, Macdonald JS.
    Cancer; 1999 Sep 01; 86(5):775-81. PubMed ID: 10463975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO.
    J Vasc Interv Radiol; 2007 Jul 01; 18(7):847-55. PubMed ID: 17609443
    [Abstract] [Full Text] [Related]

  • 8. Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.
    Mouli SK, Hickey R, Thornburg B, Sato KT, Desai K, Gabr A, Kallini JR, Niemeri H, Kircher S, Mulcahy MF, Benson Iii AB, Gupta R, Salem R, Lewandowski RJ.
    J Vasc Interv Radiol; 2016 Sep 01; 27(9):1279-1287. PubMed ID: 27062355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hazardous chemical splatter during liver chemoembolization.
    Gaba RC.
    J Vasc Interv Radiol; 2010 Nov 01; 21(11):1663-4, 1664.e1. PubMed ID: 20884232
    [No Abstract] [Full Text] [Related]

  • 12. [Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
    Shinohara K, Miura T.
    Gan To Kagaku Ryoho; 1994 Dec 01; 21 Suppl 4():558-60; discussion 560-3. PubMed ID: 7802465
    [Abstract] [Full Text] [Related]

  • 13. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
    Zhao Y, Wang SM, Zhang J.
    Ai Zheng; 2002 Apr 01; 21(4):421-3. PubMed ID: 12452025
    [Abstract] [Full Text] [Related]

  • 14. Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit.
    Popov I, Lavrnić S, Jelić S, Jezdić S, Jasović A.
    Neoplasma; 2002 Apr 01; 49(1):43-8. PubMed ID: 12044059
    [Abstract] [Full Text] [Related]

  • 15. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C.
    Hepatogastroenterology; 2003 Apr 01; 50(54):1919-26. PubMed ID: 14696433
    [Abstract] [Full Text] [Related]

  • 16. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
    Salman HS, Cynamon J, Jagust M, Bakal C, Rozenblit A, Kaleya R, Negassa A, Wadler S.
    Clin Colorectal Cancer; 2002 Nov 01; 2(3):173-9. PubMed ID: 12482334
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
    Vogl TJ, Lahrsow M, Albrecht MH, Hammerstingl R, Thompson ZM, Gruber-Rouh T.
    Eur J Radiol; 2018 May 01; 102():138-145. PubMed ID: 29685527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.